Invo Bioscience Stock Today
| INVO Stock | USD 1.17 0.13 10.00% |
Performance5 of 100
| Odds Of DistressOver 79
|
INVO Bioscience is selling at 1.17 as of the 25th of April 2024; that is -10 percent decrease since the beginning of the trading day. The stock's open price was 1.3. INVO Bioscience has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for INVO Bioscience are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 21st of May 2012 | Category Healthcare | Classification Health Care |
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. The company was founded in 2007 and is based in Sarasota, Florida. Invo Bioscience operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 2.74 M outstanding shares of which 17.55 K shares are currently shorted by private and institutional investors with about 0.7 trading days to cover. More on INVO Bioscience
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
INVO Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. INVO Bioscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding INVO Bioscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering INVO Bioscience report their recommendations after researching INVO Bioscience's financial statements, talking to executives and customers, or listening in on INVO Bioscience's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering INVO Bioscience. The INVO consensus assessment is calculated by taking the average forecast from all of the analysts covering INVO Bioscience. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from INVO Bioscience's historical financial statements, INVO Bioscience is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of INVO Bioscience is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVO Bioscience's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to INVO Bioscience's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand INVO Bioscience's financial leverage. It provides some insight into what part of INVO Bioscience's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVO Bioscience (INVO) is traded on NASDAQ Exchange in USA. It is located in 5582 Broadcast Court, Sarasota, FL, United States, 34240 and employs 25 people. INVO Bioscience is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate INVO Bioscience's market, we take the total number of its shares issued and multiply it by INVO Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. INVO Bioscience conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 2.74 M outstanding shares of which 17.55 K shares are currently shorted by private and institutional investors with about 0.7 trading days to cover.
INVO Bioscience currently holds about 1.96 M in cash with (4.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Check INVO Bioscience Probability Of Bankruptcy
Ownership AllocationRoughly 95.0 (percent) of INVO Bioscience outstanding shares are held by general public with 0.84 % owned by insiders and only 4.14 pct. by outside corporations.
Check INVO Ownership Details
INVO Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of INVO Bioscience jumping above the current price in 90 days from now is about 23.51%. The INVO Bioscience probability density function shows the probability of INVO Bioscience stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.7486. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, INVO Bioscience will likely underperform. Moreover, iNVO Bioscience has an alpha of 1.0349, implying that it can generate a 1.03 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of INVO Bioscience to move above the current price in 90 days from now is about 23.51 (This INVO Bioscience probability density function shows the probability of INVO Stock to fall within a particular range of prices over 90 days) .
INVO Stock Institutional Holders
Institutional Holdings refers to the ownership stake in INVO Bioscience that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of INVO Bioscience's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing INVO Bioscience's value.| Instituion | Recorded On | Shares | |
| Wells Fargo & Co | 2023-12-31 | 17.0 | |
| Gleason Group, Inc. | 2024-03-31 | 3.0 | |
| State Street Corporation | 2023-09-30 | 0.0 | |
| Northern Trust Corp | 2023-09-30 | 0.0 | |
| Renaissance Technologies Corp | 2023-09-30 | 0.0 | |
| Virtu Financial Llc | 2023-09-30 | 0.0 | |
| Two Sigma Securities, Llc | 2023-09-30 | 0.0 | |
| Vanguard Group Inc | 2023-12-31 | 54.1 K | |
| Citadel Advisors Llc | 2023-09-30 | 36.2 K | |
| Geode Capital Management, Llc | 2023-12-31 | 26.8 K | |
| Sabby Management Llc | 2023-12-31 | 18.6 K |
INVO Bioscience Historical Income Statement
INVO Bioscience Income Statement is one of the three primary financial statements used for reporting INVO's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of INVO Bioscience revenue and expense. INVO Bioscience Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, INVO Bioscience's Tax Provision is very stable compared to the past year. As of the 25th of April 2024, Reconciled Depreciation is likely to grow to about 323.7 K, while Interest Expense is likely to drop about 618.1 K. View More FundamentalsINVO Stock Against Markets
Picking the right benchmark for INVO Bioscience stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in INVO Bioscience stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for INVO Bioscience is critical whether you are bullish or bearish towards INVO Bioscience at a given time. Please also check how INVO Bioscience's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in INVO Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
INVO Bioscience Corporate Management
Elected by the shareholders, the INVO Bioscience's board of directors comprises two types of representatives: INVO Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of INVO. The board's role is to monitor INVO Bioscience's management team and ensure that shareholders' interests are well served. INVO Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, INVO Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin MD | Medical Director | Profile | |
| FACS FACOG | VP Integration | Profile | |
| Bojan Mitrovic | Director US | Profile | |
| Lori MarzilliKahler | VP Operations | Profile | |
| Terah Krigsvold | Controller | Profile | |
| Chris Myer | Sr Americas | Profile |
How to buy INVO Stock?
Before investing in INVO Bioscience, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in INVO Bioscience. To buy INVO Bioscience stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of INVO Bioscience. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase INVO Bioscience stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located INVO Bioscience stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased INVO Bioscience stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as INVO Bioscience, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy INVO Stock please use our How to Invest in INVO Bioscience guide.
Already Invested in INVO Bioscience?
The danger of trading INVO Bioscience is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of INVO Bioscience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than INVO Bioscience. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile INVO Bioscience is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether INVO Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of INVO Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Invo Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Invo Bioscience Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in INVO Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in INVO Stock, please use our How to Invest in INVO Bioscience guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for INVO Stock analysis
When running INVO Bioscience's price analysis, check to measure INVO Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INVO Bioscience is operating at the current time. Most of INVO Bioscience's value examination focuses on studying past and present price action to predict the probability of INVO Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INVO Bioscience's price. Additionally, you may evaluate how the addition of INVO Bioscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is INVO Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INVO Bioscience. If investors know INVO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INVO Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.13) | Revenue Per Share 1.929 | Quarterly Revenue Growth 3.968 | Return On Assets (0.34) | Return On Equity (10.61) |
The market value of INVO Bioscience is measured differently than its book value, which is the value of INVO that is recorded on the company's balance sheet. Investors also form their own opinion of INVO Bioscience's value that differs from its market value or its book value, called intrinsic value, which is INVO Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INVO Bioscience's market value can be influenced by many factors that don't directly affect INVO Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INVO Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if INVO Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INVO Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.